Article Details

NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI ...

Retrieved on: 2021-02-09 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI .... View article details on hiswai:

Excerpt

... respiratory failure being treated with the maximal standard of care that included anti-coagulants, steroids, convalescent plasma and antiviral drugs.

Article found on: www.dailyamerican.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up